Authors:
Van Coppenolle, F
Slomianny, C
Carpentier, F
Le Bourhis, X
Ahidouch, A
Croix, D
Legrand, G
Dewailly, E
Fournier, S
Cousse, H
Authie, D
Raynaud, JP
Beauvillain, JC
Dupouy, JP
Prevarskaya, N
Citation: F. Van Coppenolle et al., Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence, AM J P-ENDO, 280(1), 2001, pp. E120-E129
Authors:
Fiet, J
Giton, F
Boudi, A
Boudou, P
Vexiau, P
Galons, H
Raynaud, JP
Citation: J. Fiet et al., Highly sensitive and specific time-resolved fluoroimmunoassay (TR-FIA) of cyproterone acetate and free cyproterone, J STEROID B, 75(4-5), 2000, pp. 315-322
Authors:
Vacherot, F
Azzouz, M
Gil-Diez-de-Medina, S
Colombel, M
De la Taille, A
Belda, MAL
Abbou, CC
Raynaud, JP
Chopin, DK
Citation: F. Vacherot et al., Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon (R)) in benign prostatic hyperplasia, PROSTATE, 45(3), 2000, pp. 259-266
Authors:
Van Coppenolle, F
Le Bourhis, X
Carpentier, F
Delaby, G
Cousse, H
Raynaud, JP
Dupouy, JP
Prevarskaya, N
Citation: F. Van Coppenolle et al., Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon (R)) on rat prostate hyperplasia induced by hyperprolactinemia: Comparison with finasteride, PROSTATE, 43(1), 2000, pp. 49-58
Authors:
Iehle, C
Radvanyi, F
de Medina, SGD
Ouafik, L
Gerard, H
Chopin, D
Raynaud, JP
Martin, PM
Citation: C. Iehle et al., Differences in steroid 5 alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue, J STEROID B, 68(5-6), 1999, pp. 189-195
Authors:
Stepanov, VN
Siniakova, LA
Sarrazin, B
Raynaud, JP
Citation: Vn. Stepanov et al., Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon (R)) in benign prostatic hyperplasia: A double-blind comparison of two dosage regimens, ADV THER, 16(5), 1999, pp. 231-241